Dr Tina Biss
| Systematic analysis of the design, methodology, and patient population characteristics of the pediatric direct oral anticoagulant trials of venous thromboembolism treatment | 2025 |
|
Dr Tina Biss
| Apixaban overdose in children: case report and proposed management. A brief communication from the Pediatric and Neonatal Thrombosis and Hemostasis SSC of ISTH | 2024 |
|
Dr Tina Biss
| Considerations for instituting pediatric pulmonary embolism response teams: A tool kit | 2024 |
|
Dr Peter Carey
Dr Scott Marshall
Dr Geoff Shenton
Dr Tina Biss
Professor Roderick Skinner
et al. | Allogenic haematopoeitic stem cell transplant as cure for severe transfusion-dependent non-dominant hereditary spherocytosis due to homozygous SPTA1 mutation | 2023 |
|
Dr Tina Biss
Dr Paul Brennan
Philip Griffiths
Professor Rita Horvath
Professor Patrick Chinnery
et al. | GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements | 2022 |
|
Dr Tina Biss
Dr Katherine Talks
| Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update | 2021 |
|
Dr Tina Biss
| Pediatric May-Thurner Syndrome—Systematic review and individual patient data meta-analysis | 2021 |
|
Dr Tina Biss
Professor Farhad Kamali
| CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis | 2020 |
|
Dr Tina Biss
| Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19–related illness | 2020 |
|
Dr Katherine Talks
Dr Tina Biss
| Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B | 2020 |
|
Dr Tina Biss
| PROTECT VIII Kids: BAY 94-9027 (PEGylated Recombinant Factor VIII) safety and efficacy in previously treated children with severe haemophilia A | 2020 |
|
Dr Tina Biss
Dr John Hanley
| Therapeutic metamorphosis: Findings from a grounded theory study of the impact of low-dose prophylaxis in children living with haemophilia in India | 2020 |
|
Dr Tina Biss
| A HaemSTAR-led, UK-wide 'flash-mob' audit of intravenous immunoglobulin use in immune thrombocytopenia | 2019 |
|
Dr Tina Biss
| Characterization and treatment of congenital thrombotic thrombocytopenic purpura | 2019 |
|
Dr Lee Ferguson
Dr Kim Pearce
Dr Tina Biss
| Monitoring of Antiplatelet Therapy in Children on Ventricular Assist Device Support: Comparsion of Multiplate and Thromboelastography Platelet Mapping | 2019 |
|
Dr Kathryn Musgrave
Dr Peter Carey
Dr Tina Biss
| Myeloproliferative Neoplasms in Children and Adolescents and Thrombosis at Unusual Sites: The Role of Driver Mutations | 2019 |
|
Dr Tina Biss
| Results of a multinational survey of diagnostic and management practices of thromboembolic pulmonary embolism in children | 2019 |
|
Dr Tina Biss
| BSH Guideline: Management of thrombotic and haemostatic issues in paediatric malignancy | 2018 |
|
Dr Tina Biss
| Clinical presentation and therapeutic management of venous thrombosis in young children: A retrospective analysis | 2018 |
|
Dr Tina Biss
| Gastrointestinal Bleeding in Children With Hemophilia A | 2018 |
|
Dr Tina Biss
| Identifying Children with HEreditary Coagulation disorders (iCHEC): A protocol for a prospective cohort study | 2018 |
|
Dr Tina Biss
| Pulmonary embolism in childhood: How can we be sure not to miss it? | 2018 |
|
Dr Tom Creasey
Dr Tina Biss
Dr Peter Carey
| Pyridoxine-sensitive X-linked ‘sideroblastic’ anaemia in the absence of ring sideroblasts – molecular diagnosis | 2018 |
|
Dr Tina Biss
| Recommendations for future research in relation to pediatric pulmonary embolism: Communication from the SSC of the ISTH | 2018 |
|
Dr Emma Kampouraki
Dr Peter Avery
Dr Hilary Wynne
Dr Tina Biss
Dr John Hanley
et al. | Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: A randomised clinical trial | 2017 |
|
Dr Emma Kampouraki
Dr Peter Avery
Dr Tina Biss
Professor Farhad Kamali
| Association between CYP4F2 genotype and circulating plasma vitamin K concentration in children on chronic warfarin therapy: Possible long-term implications for bone development and vascular health | 2017 |
|
Dr Kate Musgrave
Dr Frederik van Delft
Dr Peter Avery
Dr Tina Biss
| Cerebral sinovenous thrombosis in children and young adults with acute lymphoblastic leukaemia – a cohort study from the United Kingdom | 2017 |
|
Dr Tina Biss
Professor John Dark
| Descending aortic aneurysm in Wiskott-Aldrich syndrome: options for repair | 2017 |
|
Dr Kate Musgrave
Kat Webber
Dr Peter Avery
Dr Tina Biss
| Evaluation of the age-dependent dosing recommendations for the administration of daily tinzaparin in children with thrombosis | 2017 |
|
Dr Tina Biss
| Pulmonary embolism and in situ pulmonary artery thrombosis in paediatrics: A systematic review | 2017 |
|
Dr Tina Biss
| Strategies to prevent and manage thrombotic complications of acute lymphoblastic leukemia in children and young people vary between centers in the United Kingdom | 2016 |
|
Dr Tina Biss
| Venous Thromboembolism in Children: Is It Preventable? | 2016 |
|
Dr Tina Biss
Dr Katherine Talks
| Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects | 2016 |
|
Dr John Hanley
Dr Katherine Talks
Dr Tina Biss
Paul Fearon
| Bilateral upper limb compartment syndrome induced by strenuous exercise in a patient with haemophilia A and a low titre inhibitor | 2015 |
|
Dr John Hanley
Dr Tina Biss
Dr Katherine Talks
Professor Colin Wilson
| Interventions for preventing thrombosis in solid organ transplant recipients | 2015 |
|
Dr Kate Musgrave
Dr Frederik van Delft
Dr Tina Biss
| Cerebral Venous Thrombosis As a Complication of Treatment for Acute Lymphoblastic Leukaemia in Children and Young Adults | 2014 |
|
Dr Tina Biss
Dr Peter Avery
Emily Swinburne
Professor Farhad Kamali
| Maintenance warfarin dose in children is determined by S-warfarin clearance which is in turn influenced by CYP2C9 genotype | 2014 |
|
